Monoclonal antibody F16 I 124 (Philogen)

N/A

Report date: 2025/10/20 14:43:22

Base Information

Drug NameMonoclonal antibody F16 I 124 (Philogen)
Drug Alias NameIodine-124-labelled F-16 scFv antibodyMonoclonal antibody F-16-I-124,Tenapet124I-F16F16-I-124124I-F16SIP
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibodyDiagnostic agent (In vivo)Biologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody diagnostics +[6] 
Mechanisms of ActionIonising radiation emittersDiagnostic imaging enhancers
TargetsTenascin
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesPhilogen Spa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesVu University Medical CenterPhilogen Spa
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A